Nanobiotix (NBTX) Total Debt (2018 - 2025)

Nanobiotix's Total Debt history runs 8 years deep, the most recent figure standing at $111.0 million for Q4 2025.

• On a quarterly basis, Total Debt rose 103.99% year-over-year to $111.0 million in Q4 2025; TTM through Dec 2025 was $111.0 million, a 103.99% increase from a year earlier, with the FY2025 full-year figure at $107.7 million, up 97.99% from the prior year.
• Total Debt improved to $111.0 million in Q4 2025 per NBTX's latest filing, from $58.0 million in the prior quarter.
• Across five years, Total Debt topped out at $111.0 million in Q4 2025 and bottomed at $32.7 million in Q4 2022.
• The 5-year median for Total Debt is $54.4 million (2024), against an average of $58.4 million.
• Across the five-year window, Total Debt slumped 37.87% in 2022 and surged 103.99% in 2025, its largest moves.
• Year by year, Total Debt stood at $52.6 million in 2021, then sank by 37.87% to $32.7 million in 2022, then soared by 66.33% to $54.4 million in 2023, then fell by 0.02% to $54.4 million in 2024, then jumped by 103.99% to $111.0 million in 2025.
• Per Business Quant, the three latest NBTX Total Debt figures stand at $111.0 million (Q4 2025), $58.0 million (Q2 2025), and $54.4 million (Q4 2024).